Komorowski, Matthieu http://orcid.org/0000-0003-0559-5747
Celi, Leo A. http://orcid.org/0000-0001-6712-6626
Badawi, Omar
Gordon, Anthony C. http://orcid.org/0000-0002-0419-547X
Faisal, A. Aldo
Article History
Received: 23 March 2018
Accepted: 13 August 2018
First Online: 22 October 2018
Competing interests
: The authors declare competing interests: A.C.G. reports that outside of this work he has received speaker fees from Orion Corporation Orion Pharma and Amomed Pharma. He has consulted for Ferring Pharmaceuticals, Tenax Therapeutics, Baxter Healthcare, Bristol-Myers Squibb and GSK, and received grant support from Orion Corporation Orion Pharma, Tenax Therapeutics and HCA International with funds paid to his institution. L.A.C. receives funding from Philips Healthcare. O.B. is an employee of Philips Healthcare. A.A.F. has received funding from Fresenius-KABI. M.K. does not have competing financial interests.